Page 12 - Research Models News Today

Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) COO Birgit Girshick purchased 1,322 shares of the business’s stock in a transaction dated Monday, November 20th. The shares were purchased at an average price of $187.82 per share, for a total transaction of $248,298.04. Following the acquisition, the chief operating officer now directly owns […]

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The […]

FOXO Technologies (NYSE:FOXO – Get Free Report) and Inotiv (NASDAQ:NOTV – Get Free Report) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Profitability This table compares FOXO Technologies and […]

FOXO Technologies (NYSE:FOXO – Get Free Report) and Inotiv (NASDAQ:NOTV – Get Free Report) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Institutional and Insider Ownership 31.7% of FOXO […]

– Third-Quarter Revenue of $1.03 Billion – – Third-Quarter GAAP Earnings per Share of $1.69 and Non-GAAP Earnings per Share of $2.72 – – Updates 2023 Guidance – ...

Charles River Laboratories International Inc (NYSE: CRL) reported third-quarter (Q3) sales of $1.03 billion, an increase of 3.8% Y/Y, beating the 

Envestnet Asset Management Inc. lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 179,954 shares of the medical research company’s stock after purchasing an additional 13,741 shares during […]

Revenue Growth Amidst Challenges, Non-GAAP Earnings Per Share Rise

Banco Bilbao Vizcaya Argentaria S.A. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,442 shares of the medical research company’s stock after selling 109 shares […]

Vestmark Advisory Solutions Inc. increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,370 shares of the medical research company’s stock after purchasing an additional 1,434 shares […]